I Found Out I Was Pregnant While on a GLP-1 — Here's What I Actually Learned

The search I actually typed

It was late, I was staring at a positive test I hadn't planned on, and I typed "I got pregnant while taking Ozempic" into my phone before I'd even really processed it. So if that's how you landed here, I know exactly where you are.

Short version first: GLP-1s aren't used in pregnancy — you stop as soon as you know — but if you conceived while already on one, the pooled human data are more reassuring than the label alone makes it sound. I'm not a doctor and this isn't medical advice. It's what I'd want a friend to hand me before I called mine.

Why the label says stop

The Wegovy label doesn't hedge: weight loss has no benefit for someone who's pregnant and may cause fetal harm, so the drug should be stopped once pregnancy is recognized¹. That instruction traces back to animal studies, where GLP-1 exposure was linked to lower fetal growth and skeletal, visceral, and embryonic problems². Nobody runs a pregnancy safety trial on a weight-loss drug, so there's no human trial data to weigh against that animal signal — which is exactly why obstetric medicine defaults to caution here.

What calmed me down

Because early accidental exposure isn't rare anymore, researchers have started pooling real outcomes instead of just the animal data. Two 2026 studies did that, and reading them was the thing that actually slowed my heart rate:

• One pooled six studies and 43,577 women exposed around conception and found no significant difference in major birth defects versus unexposed pregnancies³.
• Another pooled seven cohort studies, over 40,000 exposed pregnancies, and found the same thing — no significant increase in malformations, stillbirth, miscarriage, or preterm birth⁴.

Neither team calls that proof of safety, and I'm not going to pretend it is either³⁴. But "no signal across tens of thousands of pregnancies" reads a lot different at 2am than "we don't know." A broader 2026 review of this whole drug class in preconception, pregnancy, and lactation landed on the same measured note — reassuring so far, not settled yet⁵.

What I actually did

1. 1.Stopped the medication. No more doses while I figured out next steps — the one thing every source agrees on¹.
2. 2.Called my OB that same day. I told her exactly what I'd been on and when my last dose was. She'd clearly had this conversation before.
3. 3.Tried not to spiral. (I spiraled a little anyway.) The pooled data genuinely didn't show a meaningfully higher risk from my early exposure³⁴.
4. 4.Started my normal early-pregnancy routine — prenatal vitamins, my first OB visit, whatever monitoring she wanted. My goal shifted from weight loss to a healthy pregnancy from that point on.

If you're planning ahead instead of catching up

If you get to plan this instead of react to it, that's the easier version: stop before you start trying, not after a positive test. Semaglutide and tirzepatide labels don't agree on the exact runway, so read yours with your prescriber instead of assuming. If PCOS is part of your story, my PCOS piece gets into why fertility can come back faster than you'd expect once a GLP-1 is on board. And for the other side of this — once the baby's actually here — I wrote about breastfeeding on a GLP-1 and starting again postpartum too.

What I trust more, and what I trust less

"Don't use a GLP-1 in pregnancy" is the settled part — it's on the label, backed by animal data, and there's no upside to weight loss during pregnancy anyway¹². "An early accidental exposure probably didn't hurt my baby" is the newer, still-improving part — real, pooled across tens of thousands of pregnancies, but still observational, and the researchers say so themselves³⁴. I'm not going to smooth that difference over for you. It's the difference between "trust this completely" and "this is the best we've got right now, and it's genuinely reassuring."